Author

Julien Montorfani

Observed names: J Montorfani, J. Montorfani, Montorfani, Julien

Institution: Light Chain Bioscience (Switzerland)

Observed institutions: University of Geneva, Light Chain Bioscience (Switzerland)

ORCID: 0000-0001-9028-1595

Observed ORCID: 0000-0001-9028-1595

OpenAlex ID: A5039427393

IFN-γ–dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis

2022 · Laure Garnier, Robert Pick, et al. · Science Advances · 57

Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma

2025 · Mengzhu Sun, Laure Garnier, et al. · Nature Communications · 27

Selective activation of interleukin-2/interleukin-15 receptor signaling in tumor microenvironment using paired bispecific antibodies

2025 · Julien Montorfani, Eric Hatterer, et al. · Journal for ImmunoTherapy of Cancer · 3

O13.04 T he combination of innate immunity, activating tumor associated macrophages and adaptive immunity, a promising therapeutic approach in heavily treated platinum resistant ovarian cancer patient s

2026 · J Montorfani, S Martín Pastor, et al. · Journal for ImmunoTherapy of Cancer

952 A safe and tumor-selective IL-2R agonistic bispecific antibody combination for anti-tumor therapy

2024 · Julien Montorfani, Eric Hatterer · Journal for ImmunoTherapy of Cancer

207P Impact of lymphatic vessel derived oxysterol on anti-tumor immunity

2022 · M. Sun, L. Garnier, et al. · Immuno-Oncology Technology

Works count: 7

Citation count: 87

H-index: 3

I10-index: 2